Across TCGA pan-cancer cohorts, MIR483 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR483’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where MIR483 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR483 is over-expressed in tumor, although a few such as CHOL show the opposite, repressed pattern.

LIHC, BLCA, and COAD are the cancer types where MIR483 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR483 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	All	+0.362	.008	3	view →
BLCA	Male	All	+1.184	.048	2	view →
COAD	Female	All	+0.717	.034	1	view →
CHOL	Male	All	−0.261	.049	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR483 RNA expression & survival · all MIR483 data types